Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study
Simuni, T.; Brumm, M. C.; Uribe, L.; Caspell‐Garcia, C.; Coffey, C. S.; Siderowf, A. & Alcalay, R. N. et al. (2020)
Movement Disorders, 35(5) pp. 833-844. DOI: https://doi.org/10.1002/mds.27989
Documents & Media
Details
- Authors
- Simuni, Tanya; Brumm, Michael C.; Uribe, Liz; Caspell‐Garcia, Chelsea; Coffey, Christopher S.; Siderowf, Andrew; Alcalay, Roy N.; Trojanowski, John Q.; Shaw, Leslie M.; Seibyl, John; Singleton, Andrew; Toga, Arthur W.; Galasko, Doug; Foroud, Tatiana; Nudelman, Kelly; Tosun‐Turgut, Duygu; Poston, Kathleen; Weintraub, Daniel; Mollenhauer, Brit ; Tanner, Caroline M.; Kieburtz, Karl; Chahine, Lana M.; Reimer, Alyssa; Hutten, Samantha; Bressman, Susan; Marek, Kenneth
- Issue Date
- 2020
- Journal
- Movement Disorders
- ISSN
- 0885-3185
- eISSN
- 1531-8257
- ISSN
- 0885-3185
- eISSN
- 1531-8257
- Language
- English
